4//SEC Filing
Hackman Jeffrey S. 4
Accession 0001415889-24-021637
CIK 0001211583other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:59 PM ET
Size
6.2 KB
Accession
0001415889-24-021637
Insider Transaction Report
Form 4
Hackman Jeffrey S.
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2024-08-15$5.58/sh+400,000$2,232,000→ 400,000 totalExercise: $5.58From: 2025-08-05Exp: 2034-08-05→ Common Shares (400,000 underlying)
Footnotes (2)
- [F1]On August 15, 2024, Jeffrey Hackman was granted incentive stock options to purchase 400,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F2]One-third of the shares subject to this option may be exercised as of August 5, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of August 5, 2027, 100% of the total number of shares subject to this option shall be vested.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001926254
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:59 PM ET
- Size
- 6.2 KB